Cargando…
Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
BACKGROUND: The use of fecal calprotectin (FCal) as a marker of intestinal inflammation, in the management of inflammatory bowel disease (IBD) is increasing. The aim of this study was to examine the impact of FCal measurements on decision-making and clinical care of children with IBD. MATERIALS AND...
Autores principales: | El-Matary, Wael, Abej, Esmail, Deora, Vini, Singh, Harminder, Bernstein, Charles N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263122/ https://www.ncbi.nlm.nih.gov/pubmed/28180127 http://dx.doi.org/10.3389/fped.2017.00007 |
Ejemplares similares
-
The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016) -
Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017) -
Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2020) -
Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective
por: El-Matary, Wael, et al.
Publicado: (2018) -
Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
por: Ho, Shaun S. C., et al.
Publicado: (2021)